A5079043530- Opioid Use Disorder Treatment
- Substance Abuse Treatment and Outcomes
- Prenatal Substance Exposure Effects
- Pharmaceutical Practices and Patient Outcomes
- HIV, Drug Use, Sexual Risk
- Elder Abuse and Neglect
- HIV/AIDS Research and Interventions
- Mental Health Treatment and Access
- LGBTQ Health, Identity, and Policy
- Intimate Partner and Family Violence
- Health disparities and outcomes
- Pain Management and Opioid Use
- Poisoning and overdose treatments
- Schizophrenia research and treatment
- Health Systems, Economic Evaluations, Quality of Life
- Medical Malpractice and Liability Issues
- Retirement, Disability, and Employment
- Criminal Justice and Corrections Analysis
- Pharmaceutical Economics and Policy
- Reproductive Health and Technologies
- Insurance, Mortality, Demography, Risk Management
- Family Caregiving in Mental Illness
- Interprofessional Education and Collaboration
- Cardiac Arrest and Resuscitation
- Gender, Labor, and Family Dynamics
Weill Cornell Medicine
2017-2024
Cornell University
2017-2024
University of California, Los Angeles
2024
New York Hospital Queens
2023
Presbyterian Hospital
2023
NewYork–Presbyterian Hospital
2023
Icahn School of Medicine at Mount Sinai
2020
New York State Psychiatric Institute
2020
University of Washington
2018
Comprehensive mandates for prescription drug monitoring programs (PDMPs) require state-licensed prescribers and dispensers both to register with use the in most clinical circumstances. Such have potential improve providers' participation reduce opioid-related adverse events. Using Medicaid data hospital utilization across US period 2011–16, we found that state implementation of comprehensive PDMP was associated a reduction opioid rate from 161.47 147.07 per 1,000 enrollees quarter, inpatient...
Abstract Background and aims Opioid overdose is a leading cause of death during the immediate time after release from jail or prison. Most jails in United States do not provide methadone buprenorphine treatment for opioid use disorder (MOUD), research estimating its impact settings limited. We aimed to test hypothesis that in‐jail MOUD associated with lower mortality risk post‐release. Design, setting participants Retrospective, observational cohort study 15 797 adults who were released New...
Policies and practices have proliferated to optimize prescribers’ use of their states’ prescription drug monitoring programs, which are statewide databases controlled substances dispensed at retail pharmacies. Our study assessed the effectiveness three such policies: comprehensive legislative mandates program, laws that allow prescribers delegate its office staff, state participation in interstate data sharing. analysis information from a large commercial insurance database indicated...
Background: Not enough evidence exists to compare buprenorphine–naloxone with extended-release naltrexone for treating opioid use disorder. Objective: To evaluate the cost-effectiveness of versus naltrexone. Design: Cost-effectiveness analysis alongside a previously reported randomized clinical trial 570 adults in 8 U.S. inpatient or residential treatment programs. Data Sources: Study instruments. Target Population: Adults Time Horizon: 24-week intervention an additional 12 weeks...
Given the personal and public consequences of untreated/undertreated OUD among persons involved in justice system, an increasing number jails prisons are incorporating medication for opioid use disorder (MOUD) into their system. Estimating costs implementing sustaining a particular MOUD program is vital to detention facilities, which typically face modest, fixed health care budgets. We developed customizable budget impact tool estimate implementation sustainment numerous delivery models...
Elder mistreatment is common and has serious health consequences. Little known, however, about patterns of care utilization among older adults experiencing elder mistreatment. To examine emergency department (ED) hospital in the period surrounding initial identification compared with other adults. This retrospective case-control study used Medicare insurance claims to initially identified between January 1, 2003, December 31, 2012, control participants matched on age, sex, race ethnicity,...
Objective To estimate the own‐price elasticity of demand for naloxone, a prescription medication that can counter effects an opioid overdose, and predict change in pharmacy sales following conversion to over‐the‐counter status. Data Sources/Study Setting The primary data source was nationwide claims dataset 2010‐2017. cover 80 percent US retail pharmacies account roughly 90 prescriptions filled. Additional covariates were obtained from various secondary sources. Study Design We estimated...
Medicaid program criteria for accessing hepatitis C treatment are changing. drug utilization data from 2014 to 2016 show that programs have relaxed their seen significant increases in utilization, as states with expansions.
This study examined whether psychiatric case review was associated with depression medication modification in a large implementation program of collaborative care for safety-net primary clinics.Registry data were from an the model Washington State. A total 14,960 adults 178 clinics who initiated between January 1, 2008, and September 30, 2014, had baseline Patient Health Questionnaire-9 (PHQ-9) score 10 or higher included. Rates reviews receipt new medications extracted registry all patients...
Abstract Background Persons with an opioid use disorder (OUD) who were incarcerated face many challenges to remaining abstinent; concomitantly, opioid-overdose is the leading cause of death among this population, initial weeks following release proving especially fatal. Extended-release naltrexone (XR-NTX) most widely-accepted, evidence-based OUD pharmacotherapy in criminal justice settings, and ensures approximately 30 days protection from overdose. The high cost XR-NTX serves as a barrier...
A health care encounter is a potentially critical opportunity to detect elder abuse and initiate intervention. Unfortunately, providers currently very seldom identify abuse. Through development of advanced data analytics techniques such as machine learning, artificial intelligence has the potential dramatically improve identification in settings.
Background: Since early 2016, an increasing number of states passed legislations that limit the duration and/or dosage initial opioid prescriptions or opioids for acute pain. Objective: The objective this study was to assess changes in covered by Medicaid and received patients associated with state implementation legislative limits on prescriptions. Research Design: We explored natural experiment resulting from staggered limits. analysis adopted a Difference-in-Differences framework...
A strengthened evidence base and earmarked federal funding have spurred the implementation of coordinated specialty care (CSC) for people experiencing early psychosis. However, existing mechanisms are insufficient unsustainable to support population-wide deployment CSC. This article describes design framework an innovative payment model CSC that includes a bundled case rate optional outcome-based payment. To assist payer provider organizations in designing systems tailored local preferences...
State policies to optimize prescriber use of Prescription Drug Monitoring Programs (PDMPs) have proliferated in recent years. Prominent include comprehensive mandates for PDMP, laws allowing delegation PDMP access office staff, and interstate data sharing. Evidence is limited regarding the effects these on adverse opioid-related hospital events.The objective this study was assess 3 events among patients with prescription opioid use.We examined 2011-2015 from a large national commercial...
Naloxone distributed to people at risk for opioid overdose has been associated with reduced death rates; however, associations of retail pharmacy-distributed naloxone mortality have not evaluated. Our analytic cohort uses pharmacy claims data; three health departments' community distribution federal and American Community Survey data. Data were analyzed by 3-digit ZIP Code calendar quarter-year (2016Q1–2018Q4), weighted population. We regressed opioid-related on retail-pharmacy distribution,...